SCHEMBL29960701

SCHEMBL29960701

COc1cccc2c1C(Cl)CCO2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K14 Q99558 1/20 0.45
HTR1A P08908 4/20 0.39
CTNNB1 P35222 1/20 0.38
WNT3A P56704 1/20 0.38
ABCB1 P08183 1/20 0.36
HTR2A P28223 2/20 0.35
HCRTR1 O43613 2/20 0.35
HCRTR2 O43614 2/20 0.35
CYP19A1 P11511 1/20 0.35
ALDH1A1 P00352 2/20 0.35
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
KDM4E B2RXH2 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
DRD2 P14416 1/20 0.34
DRD1 P21728 1/20 0.34
HTR1B P28222 1/20 0.34
HTR2C P28335 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29960150 0.82 MAP3K14 (0.63) MAP3K14HTR1ACTNNB1WNT3AABCB1
SCHEMBL19829900 0.81 MAP3K14 (0.45) MAP3K14HTR1ACTNNB1WNT3AABCB1
SCHEMBL23841360 0.78 MAP3K14 (0.46) MAP3K14HTR1ACTNNB1WNT3AABCB1
SCHEMBL3561436 0.78 MAP3K14 (0.67) MAP3K14HTR2AALDH1A1HTR2C
SCHEMBL29960553 0.77 MAP3K14 (0.42) MAP3K14HTR1ACTNNB1WNT3AABCB1
SCHEMBL20480690 0.77 MAP3K14 (0.42) MAP3K14HTR1ACTNNB1WNT3AABCB1
Hydrochloric Acid SCHEMBL29960788 0.76 HTR1A (0.54) MAP3K14HTR1ACTNNB1WNT3AHTR2A
SCHEMBL20480545 0.76 PTGDR2 (0.45) MAP3K14HTR1ACTNNB1WNT3A
SCHEMBL20480263 0.75 MAP3K14 (0.43) MAP3K14HTR1ACTNNB1WNT3ACYP19A1
SCHEMBL3553150 0.75 MAP3K14 (0.45) MAP3K14ABCB1TP53HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204150-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS BLUE OAK PHARMACEUTICALS, INC. (US) 2022-09-29 WO disclosed